Gabriela Petrof
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
A unique poikilodermatous condition associated with a de novo heterozygous ATR missense variant.
Journal: Clinical and experimental dermatology
Published: February 23, 2026
Eliciting health state utilities for open wounds in dystrophic epidermolysis bullosa.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: January 16, 2026
O01 Infantile bullous pemphigoid: when autoimmunity hides an immunodeficiency.
Journal: The British journal of dermatology
Published: December 18, 2025
O05 Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition.
O05 Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition.
Journal: The British journal of dermatology
Published: December 18, 2025
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.
Journal: The British journal of dermatology
Published: December 18, 2025
Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa patients with nonsense COL7A1 mutations.
Journal: Clinical and experimental dermatology
Published: November 26, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial.
Journal: Orphanet journal of rare diseases
Published: October 23, 2025
Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR.
Journal: Journal of clinical immunology
Published: October 06, 2025
Assessment of hand contractures in epidermolysis bullosa (ACE-EB): Describing the development of a novel hand assessment for children.
Journal: Hand therapy
Published: September 12, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.
Journal: BMJ open
Published: May 21, 2025
Topical JAK inhibitor for refractory skin inflammation in STAT1 GOF.
Journal: Journal of human immunity
Published: March 28, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase.
Journal: EClinicalMedicine
Published: March 11, 2025
Last Updated: 09/26/2026